EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis

Jiamu Qu, Dingde Ye, Yang Sun, Ting Fang, Xianzhong He, Qing Ge, Zhenwen Li, Xiang Cao, Qiang Wang, Guoqiang Li, Beicheng Sun

Current Molecular Pharmacology · 2026 · 19 (1) · 133-142

DOI: 10.1016/j.cmp.2026.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Jiamu Qu und 10 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qu, J., Ye, D., Sun, Y., Fang, T., He, X., Ge, Q., Li, Z., Cao, X., Wang, Q., Li, G., & Sun, B. (2026). HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis. Current Molecular Pharmacology, 19(1), 133-142. https://doi.org/10.1016/j.cmp.2026.06.003

Vancouver

Qu J, Ye D, Sun Y, Fang T, He X, Ge Q, et al. HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis. Current Molecular Pharmacology. 2026;19(1):133-142. doi:10.1016/j.cmp.2026.06.003

BibTeX
@article{Qu2026,
  author = {Qu, Jiamu and Ye, Dingde and Sun, Yang and Fang, Ting and He, Xianzhong and Ge, Qing and Li, Zhenwen and Cao, Xiang and Wang, Qiang and Li, Guoqiang and Sun, Beicheng},
  title = {HNMT promotes hepatocellular carcinoma progression by up-regulation of VTN/ECM axis},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {133--142},
  doi = {10.1016/j.cmp.2026.06.003}
}
Kostenlos starten →